Research projects under investigation:
  • Role of SDF1 and CXCR4 in breast cancer metastasis
  • Discovery and Validation of novel tissue and plasma biomarkers in breast cancer
  • Mechanisms of resistance to herceptin in breast cancer
  • Discovery and validation of genomic alterations in colon and breast cancer as a guide to novel therapeutic targets
  • Discovery of novel tumor suppressor genes in breast cancer using Nonsense-Mediated RNA decay
  • Technology consortium for the creation of reverse-phase protein microarrays for the validation of serum markers in cancer patients
  • Targeting tumor stroma for cancer therapeutics in breast cancer
Current Technological Platforms: 
  • Agilent Whole-genome oligonucleotide microarrays
  • Agilent array-Comparative Genomic Hybridization
  • Tissue microarrays
  • Reverse-Phase Protein Microarrays 

Support research at the Lady Davis Institute - Jewish General Hospital